A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma

NCT06860971 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Thyroid Cancer

Interventions

DRUG: AL2846 Capsules
DRUG: AL2846 Placebo

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.